zum Inhalt wechseln
Endocannabinoid regulation of monoamines in psychiatric and neurological disorders Titelvorschau
SchließenTitelvorschau
Prüfung…

Endocannabinoid regulation of monoamines in psychiatric and neurological disorders

Verfasser/in: Elisabeth J Van Bockstaele
Verlag: New York : Springer, ©2013.
Ausgabe/Format   E-Book : Dokument : EnglischAlle Ausgaben und Formate anzeigen
Datenbank:WorldCat
Zusammenfassung:
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing  Weiterlesen…
Bewertung:

(noch nicht bewertet) 0 mit Rezensionen - Verfassen Sie als Erste eine Rezension.

Themen
Ähnliche Titel

 

Online anzeigen

Links zu diesem Titel

Exemplar ausleihen

&AllPage.SpinnerRetrieving; Suche nach Bibliotheken, die diesen Titel besitzen ...

Details

Gattung/Form: Electronic books
therapeutic use
drug therapy
Physisches Format Print version:
Endocannabinoid regulation of monoamines in psychiatric.
[S.l.] : Springer-Verlag New York, 2013
(OCoLC)841520677
Medientyp: Dokument, Internetquelle
Dokumenttyp: Internet-Ressource, Computer-Datei
Alle Autoren: Elisabeth J Van Bockstaele
ISBN: 9781461479406 1461479401 1461479398 9781461479390
OCLC-Nummer: 852471079
Anmerkungen: Includes index.
Beschreibung: 1 online resource.
Inhalt: Endocannabinoids and monoamines: modulating the modulators --
Endocannabinoid-mediated synaptic plasticity --
Current cannabinoid receptor nomenclature and pharmacological principles --
Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction --
Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders --
Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers --
Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion --
Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function --
Endocannabinoids, Monoamines and Stress --
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders --
Endocannabinoid Signaling and the Regulation of the Serotonin System --
Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors --
Involvement of serotonergic system in cannabinoid analgesia --
Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.
Verfasserangabe: Elisabeth J. van Bockstaele, editor.
Weitere Informationen:

Abstract:

Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders  Weiterlesen…

Rezensionen

Redaktionelle Rezension

Nielsen BookData

From the reviews: "This book reviews the expansion of our understanding of cannabinoid modulation of monoaminergic circuits and their interactions in a variety of psychiatric and neurological Weiterlesen…

 
Nutzer-Rezensionen
Suche nach GoodReads-Rezensionen
Suche nach DOGObooks-Rezensionen…

Tags

Tragen Sie als Erste Tags ein.
Anfrage bestätigen

Sie haben diesen Titel bereits angefordert. Wenn Sie trotzdem fortfahren möchten, klicken Sie auf OK.

Verlinkung


<http://www.worldcat.org/oclc/852471079>
library:oclcnum"852471079"
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:contributor
schema:copyrightYear"2013"
schema:datePublished"2013"
schema:description"The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in a variety of psychiatric (affective disorders) and neurological disorders (multiple sclerosis, pain). Despite increasing evidence from preclinical data suggesting that therapeutic use of cannabinoid-based drugs may outweigh any potential risks in certain serious medical conditions, the debate surrounding its widespread utility continues as regulatory concerns preclude a smooth transition of promising preclinical studies into clinical trial testing. This may persist in the near future as state and federal governments debate over regulation of medicinal applications of cannabis. Applications for medicinal cannabinoids that are already under investigation include the treatment of nausea, anorexia, neurodegeneration, inflammation, excitotoxicity and pain. The appetitive and anti-emetic properties of cannabinoids have led to the approval of their use in chemotherapy and AIDS patients. There is growing evidence for therapeutic cannabinoid effects on inflammatory and excitotoxic cellular processes that are linked to epilepsy, Parkinson's disease, amyotrophic lateral sclerosis, spasticity, and central nervous system injury. The chapters, herein, review and discuss current insights into the brain endocannabinoid system, cannabinoid receptor signaling on synaptic plasticity, potential therapeutic applications with a particular focus on endocannabinoid modulation of dopaminergic, noradrenergic and serotonergic circuitry. The potential for establishing cannabinoid-monoaminergic interactions as a novel target in the development of improved treatment strategies for psychiatric and neurological disorders is promising and will require future clinical studies to determine whether promising pre-clinical findings translate into new therapies."
schema:description"Endocannabinoids and monoamines: modulating the modulators -- Endocannabinoid-mediated synaptic plasticity -- Current cannabinoid receptor nomenclature and pharmacological principles -- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction -- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders -- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers -- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion -- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function -- Endocannabinoids, Monoamines and Stress -- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders -- Endocannabinoid Signaling and the Regulation of the Serotonin System -- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors -- Involvement of serotonergic system in cannabinoid analgesia -- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis."
schema:exampleOfWork<http://worldcat.org/entity/work/id/1411312578>
schema:genre"Electronic books"
schema:inLanguage"en"
schema:name"Endocannabinoid regulation of monoamines in psychiatric and neurological disorders"
schema:publication
schema:publisher
schema:url<http://site.ebrary.com/id/10733550>
schema:url<http://dx.doi.org/10.1007/978-1-4614-7940-6>
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=606343>
schema:url<http://lib.myilibrary.com?id=517034>
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

Fenster schließen

Bitte in WorldCat einloggen 

Sie haben kein Konto? Sie können sehr einfach ein kostenloses Konto anlegen,.